Search
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Abstract
Citations
-
2 1 2
CrossRef
-
0
Web of Science
-
2 2 1
Scopus
Authors (23)
-
Andrew Zelenetz
-
Jacqueline Barrientos
-
Jennifer Brown
-
Bertrand Coiffier
-
Julio Delgado
-
Miklós Egyed
-
Paolo Ghia
-
Árpád Illés
-
-
Paula Marlton
-
Marco Montillo
-
Franck Morschhauser
-
Alexander Pristupa
-
Tadeusz Robak
-
Jeff Sharman
-
David Simpson
-
Lukáš Smolej
-
Eugen Tausch
-
Adeboye Adewoye
-
Lyndah Dreiling
-
Yeonhee Kim
-
Stephan Stilgenbauer
-
Peter Hillmen
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
LANCET ONCOLOGY
no. 18,
edition 3,
pages 297 - 311,
ISSN: 1470-2045 - ISSN:
- 1470-2045
- Publication year:
- 2017
- DOI:
- Digital Object Identifier (open in new tab) 10.1016/s1470-2045(16)30671-4
- Verified by:
- No verification
seen 93 times